Work

Outcomes of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm Who Received Hematopoietic Stem Cell Transplantation Following Remission Induction with Tagraxofusp, a Targeted Therapy Directed to CD123

FWCI: 0.13
Cites:
Cited by: 1
Related to: 10